Structural basis of epitope recognition by heavy-chain camelid antibodies
Abstract
Truncated versions of heavy-chain antibodies (HCAbs) from camelids, also termed nanobodies, comprise only one-tenth the mass of conventional antibodies, yet retain similar, high binding affinities for the antigens. Here we analyze a large data set of nanobody-antigen crystal structures and investigate how nanobody-antigen recognition compares to the one by conventional antibodies. We find that nanobody paratopes are enriched in aromatic residues just like conventional antibodies, but additionally, they also bear a more hydrophobic character. Most striking differences were observed in the characteristics of the antigen's epitope. Unlike conventional antibodies, nanobodies bind to more rigid, concave, conserved and structured epitopes enriched with aromatic residues. Nanobodies establish fewer interactions with the antigens compared to conventional antibodies, and we speculate that high binding affinities are achieved due to less unfavorable conformational and more favorable solvation entropy contributions. We observed that interactions with antigen are mediated not only by three CDR loops but also by numerous residues from the nanobody framework. These residues are not distributed uniformly; rather, they are concentrated into four structurally distinct regions and mediate mostly charged interactions. Our findings suggest that in some respects nanobody-antigen interactions are more similar to the general protein-protein interactions rather than antibody-antigen interactions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The extended CDR3 loop of nanobodies has the capacity to form a finger-like structure with greater structural flexibility, likely fixed in one single conformation upon antigen-binding.
“The extended CDR3 loop of nanobodies has the capacity to form a finger-like structure with greater structural flexibility which, in turn, is likely fixed in one single conformation upon antigen-binding [14,15].”
From Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments (2020) · cites this paper as [14]
Cites
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392 · see citing works
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320 · see citing works
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W.-Z., & Godzik, A. (2006) · Bioinform. · doi:10.1093/bioinformatics/btl158 · Cited by 10,994 · see citing works
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080 · see citing works
Biometry: The Principles and Practice of Statistics in Biological Research
Campbell, R. C., Sokal, R. R., & Rohlf, F. J. (1970) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2343822 · Cited by 3,972 · see citing works
Prediction of protein antigenic determinants from amino acid sequences.
Hopp, T. P., & Woods, K. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3824 · Cited by 3,726 · see citing works
Naturally occurring antibodies devoid of light chains
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Songa, E. B., Bendahman, N., & Hammers, R. (1993) · Nature · doi:10.1038/363446a0 · Cited by 3,241 · see citing works
Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw408 · Cited by 3,163 · see citing works
Nanobodies: natural single-domain antibodies
Muyldermans, S. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-063011-092449 · Cited by 2,304 · see citing works
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,967 · see citing works
Structure and function of immunoglobulins
Schroeder, H. W., & Cavacini, L. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.046 · Cited by 1,923 · see citing works
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,663 · see citing works
Shape Complementarity at Protein/Protein Interfaces
Lawrence, M. C., & Colman, P. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1648 · Cited by 1,219 · see citing works
Shape complementarity at protein–protein interfaces
Norel, R., Lin, S. L., Wolfson, H. J., & Nussinov, R. (1994) · Biopolymers · doi:10.1002/bip.360340711 · Cited by 1,208 · see citing works
Conformations of immunoglobulin hypervariable regions
Chothia, C., Lesk, A. M., Tramontano, A. L., Levitt, M., Smith‐Gill, S. J., Air, G. M., Sheriff, S., PADLAN, E. A., Davies, D. R., Tulip, W. R., et al. (1989) · Nature · doi:10.1038/342877a0 · Cited by 1,185 · see citing works
Anatomy of the antibody molecule
PADLAN, E. A. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90001-9 · Cited by 897 · see citing works
Structural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A., Laeremans, T., Feinberg, E. N., Sanborn, A. L., KATO, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 895 · see citing works
Lefranc, M., Pommie, C., Ruíz, M., Giudicelli, V., Foulquier, E., Truong, L., Contet, V., & Lefranc, G. (2002) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(02)00039-3 · Cited by 823 · see citing works
Lefranc, M., Pommie, C., Kaas, Q., Duprat, É., Bosc, N., Guiraudou, D., Jean, C., Ruíz, M., da Piedade, I., Rouard, M., et al. (2004) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2004.07.003 · Cited by 808 · see citing works
Negative selection of lymphocytes
Nossal, G. J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90331-x · Cited by 794 · see citing works
Greenberg, A. S., Avila, D. W., Hughes, M. K., Hughes, A. L., McKinney, E. C., & Flajnik, M. F. (1995) · Nature · doi:10.1038/374168a0 · Cited by 783 · see citing works
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
Genst, E. D., Silence, K., Decanniere, K., Conrath, K., Loris, R., Kinne, J., Muyldermans, S., & Wyns, L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505379103 · Cited by 681 · see citing works
Self-citationPeer Bork, B., Holm, L., & Sander, C. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1582 · Cited by 676 · see citing works
Prediction of residues in discontinuous B‐cell epitopes using protein 3D structures
Andersen, P. H., Nielsen, M., & Lund, O. (2006) · Protein Science · doi:10.1110/ps.062405906 · Cited by 631 · see citing works
Ma, B., Elkayam, T., Wolfson, H., & Nussinov, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1030237100 · Cited by 595 · see citing works
Correlation between segmental mobility and the location of antigenic determinants in proteins
Westhof, É., Altschuh, D., Moras, D., Bloomer, A. C., Mondragón, A., Klug, A., & Regenmortel, M. H. V. V. (1984) · Nature · doi:10.1038/311123a0 · Cited by 587 · see citing works
The structural basis of antibody–antigen recognition
Sela-Culang, I., Kunik, V., & Ofran, Y. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00302 · Cited by 530 · see citing works
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
Desmyter, A., Transue, T. R., Ghahroudi, M. A., Thi, M. H. D., Poortmans, F., HAMERS, R., Muyldermans, S., & Wyns, L. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0996-803 · Cited by 525 · see citing works
Fluorescent fusion protein knockout mediated by anti-GFP nanobody
Caussinus, E., Kanca, O., & Affolter, M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2180 · Cited by 510 · see citing works
Potent enzyme inhibitors derived from dromedary heavy‐chain antibodies
Lauwereys, M., Ghahroudi, M. A., Desmyter, A., Kinne, J., Hölzer, W., Genst, E. D., Wyns, L., & Muyldermans, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3512 · Cited by 492 · see citing works
Nanobodies as therapeutics: big opportunities for small antibodies
Steeland, S., Vandenbroucke, R. E., & Libert, C. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.04.003 · Cited by 462 · see citing works
Mayrose, I. (2004) · Molecular Biology and Evolution · doi:10.1093/molbev/msh194 · Cited by 448 · see citing works
Neuvirth, H., Raz, R., & Schreiber, G. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.040 · Cited by 436 · see citing works
ANARCI: antigen receptor numbering and receptor classification
Dunbar, J., & Deane, C. M. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv552 · Cited by 421 · see citing works
Fellouse, F. A., Esaki, K., Birtalan, S., Raptis, D. A., Cancasci, V. J., Koide, A., Jhurani, P., Vasser, M., Wiesmann, C., Kossiakoff, A. A., et al. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.08.005 · Cited by 359 · see citing works
Comparison of llama VH sequences from conventional and heavy chain antibodies
Bang, V. K., Ghahroudi, M. A., Wyns, L., & Muyldermans, S. (1997) · Molecular Immunology · doi:10.1016/s0161-5890(97)00146-6 · Cited by 344 · see citing works
Fellouse, F. A., Wiesmann, C., & Sidhu, S. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401786101 · Cited by 305 · see citing works
Structural analysis of B-cell epitopes in antibody: protein complexes
Kringelum, J. V., Nielsen, M., Padkjær, S. B., & Lund, O. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.06.001 · Cited by 305 · see citing works
Novotný, J., Handschumacher, M. D., Haber, E., Bruccoleri, R. E., Carlson, W. B., Fanning, D. W., Smith, J. A., & Rose, G. D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.226 · Cited by 303 · see citing works
Location of ‘continuous’ antigenic determinants in the protruding regions of proteins.
Thornton, J. M., Edwards, M. S., Taylor, W. R., & Barlow, D. J. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04226.x · Cited by 282 · see citing works
Molecular recognition in antibody-antigen complexes
Sundberg, E. J., & Mariuzza, R. A. (2002) · Advances in protein chemistry · doi:10.1016/s0065-3233(02)61004-6 · Cited by 255 · see citing works
Exploiting Nanobodies’ Singular Traits
Ingram, J. R., Schmidt, F. I., & Ploegh, H. L. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053327 · Cited by 254 · see citing works
Computational characterization of B-cell epitopes
Rubinstein, N. D., Mayrose, I., Halperin, D., Yekutieli, D., Gershoni, J. M., & Pupko, T. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.016 · Cited by 251 · see citing works
Nanobody stabilization of G protein-coupled receptor conformational states
Steyaert, J., & Kobilka, B. K. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.06.011 · Cited by 234 · see citing works
Comparative analysis of nanobody sequence and structure data
Mitchell, L. S., & Colwell, L. J. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25497 · Cited by 233 · see citing works
Koide, S., & Sidhu, S. S. (2009) · ACS Chemical Biology · doi:10.1021/cb800314v · Cited by 216 · see citing works
Origins of specificity and affinity in antibody–protein interactions
Peng, H., Lee, K. H., Jian, J.-W., & Yang, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401131111 · Cited by 209 · see citing works
Beghein, E., & Gettemans, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00771 · Cited by 190 · see citing works
Ramaraj, T., Angel, T. E., Dratz, E. A., Jesaitis, A. J., & Mumey, B. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.12.007 · Cited by 181 · see citing works
Water at biomolecular binding interfaces
Li, Z., & Lazaridis, T. (2006) · Physical Chemistry Chemical Physics · doi:10.1039/b612449f · Cited by 179 · see citing works
Three Camelid VHH Domains in Complex with Porcine Pancreatic α-Amylase
Desmyter, A., Spinelli, S., Payan, F., Lauwereys, M., Wyns, L., Muyldermans, S., & Cambillau, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202327200 · Cited by 171 · see citing works
Burgoyne, N. J., & Jackson, R. M. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl079 · Cited by 166 · see citing works
Decanniere, K., Desmyter, A., Lauwereys, M., Ghahroudi, M. A., Muyldermans, S., & Wyns, L. (1999) · Structure · doi:10.1016/s0969-2126(99)80049-5 · Cited by 159 · see citing works
Nanobodies®: New ammunition to battle viruses
Vanlandschoot, P., Stortelers, C., Beirnaert, E., Ibañez, L. I., Schepens, B., Depla, E., & Saelens, X. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.09.002 · Cited by 135 · see citing works
Crystal Structure of the Intrinsically Flexible Addiction Antidote MazE
Loris, R., Marianovsky, I., Lah, J., Laeremans, T., Engelberg–Kulka, H., Glaser, G., Muyldermans, S., & Wyns, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302336200 · Cited by 123 · see citing works
Self-citationNguyen, V. K., HAMERS, R., Wyns, L., & Muyldermans, S. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00067-x · Cited by 119 · see citing works
Decanniere, K., Muyldermans, S., & Wyns, L. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3839 · Cited by 106 · see citing works
Single-Domain Antibodies As Therapeutics against Human Viral Diseases
Wu, Y., Jiang, S., & Ying, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01802 · Cited by 105 · see citing works
Kunik, V., & Ofran, Y. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt027 · Cited by 96 · see citing works
Antibody and antigen contact residues define epitope and paratope size and structure
Stave, J. W., & Lindpaintner, K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203198 · Cited by 92 · see citing works
Analysis and modeling of the variable region of camelid single-domain antibodies
Sircar, A., Sanni, K. A., Shi, J., & Gray, J. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100116 · Cited by 92 · see citing works
Exploiting sequence and structure homologs to identify protein–protein binding sites
Chung, J., Wang, W., & Bourne, P. E. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20741 · Cited by 87 · see citing works
Rossey, I., Gilman, M. S. A., Kabeche, S. C., Sedeyn, K., Wrapp, D., Kanekiyo, M., Chen, M., Más, V., Spitaels, J., Melero, J. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14158 · Cited by 84 · see citing works
Side‐chain conformational entropy at protein–protein interfaces
Cole, C., & Warwicker, J. (2002) · Protein Science · doi:10.1110/ps.0222702 · Cited by 83 · see citing works
Ofran, Y., Schlessinger, A., & Rost, B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6230 · Cited by 81 · see citing works
Kuroda, D., & Gray, J. J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw197 · Cited by 81 · see citing works
Chemical Basis for the Affinity Maturation of a Camel Single Domain Antibody
Genst, E. D., Handelberg, F., Meirhaeghe, A. V., Vynck, S., Loris, R., Wyns, L., & Muyldermans, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407843200 · Cited by 78 · see citing works
Self-citationNanobody Binding to a Conserved Epitope Promotes Norovirus Particle Disassembly
Koromyslova, A. D., & Hansman, G. S. (2014) · Journal of Virology · doi:10.1128/jvi.03176-14 · Cited by 72 · see citing works
The interfacial character of antibody paratopes: analysis of antibody–antigen structures
Nguyen, M. N., Pradhan, M. R., Verma, C. S., & Zhong, P. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx389 · Cited by 71 · see citing works
Chen, S. W., Regenmortel, M. H. V. V., & Pellequer, J. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581914 · Cited by 68 · see citing works
Li, X., Duan, X., Yang, K., Zhang, W., Zhang, C., Fu, L., Ren, Z., Wang, C., Wu, J., Lu, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161801 · Cited by 65 · see citing works
Cation–π, amino–π, π–π, and H‐bond interactions stabilize antigen–antibody interfaces
Dalkas, G. A., Teheux, F., Kwasigroch, J. M., & Rooman, M. J. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24527 · Cited by 60 · see citing works
Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies
Chaikuad, A., Keates, T., Vincke, C., Kaufholz, M., Zenn, M., Zimmermann, B., Gutiérrez, C., Zhang, R.-G., Hatzos-Skintges, C., Joachimiak, A., et al. (2014) · Biochemical Journal · doi:10.1042/bj20131399 · Cited by 59 · see citing works
Ribosome-dependent Vibrio cholerae mRNAse HigB2 is regulated by a β-strand sliding mechanism
Hadži, S., Garcia‐Pino, A., Haesaerts, S., Jurėnas, D., Gerdes, K., Lah, J., & Loris, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx138 · Cited by 54 · see citing works
Self-citationDalkas, G. A., & Rooman, M. J. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1528-9 · Cited by 52 · see citing works
Reassessing buried surface areas in protein–protein complexes
Chakravarty, D., Guharoy, M., Robert, C. H., Chakrabarti, P., & Janin, J. (2013) · Protein Science · doi:10.1002/pro.2330 · Cited by 49 · see citing works
Sun, J., Xu, T., Wang, S., Li, G., Wu, D., & Cao, Z. (2011) · Immunome Research · Cited by 41 · see citing works
Koch, K., Kalusche, S., Torres, J. L., Stanfield, R. L., Danquah, W., Khazanehdari, K. A., von Briesen, H., Geertsma, E. R., Wilson, I. A., Wernery, U., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08273-7 · Cited by 41 · see citing works
Nanobody-Directed Specific Degradation of Proteins by the 26S-Proteasome in Plants
Baudisch, B., Pfort, I., Sorge, E., & Conrad, U. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00130 · Cited by 41 · see citing works
Free Energies and Entropies of Water Molecules at the Inhibitor−Protein Interface of DNA Gyrase
Yu, H., & Rick, S. W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja809696s · Cited by 39 · see citing works
Shape complementarity of protein–protein complexes at multiple resolutions
Zhang, Q., Sanner, M. F., & Olson, A. J. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22256 · Cited by 37 · see citing works
Constraining Enzyme Conformational Change by an Antibody Leads to Hyperbolic Inhibition
Oyen, D., Srinivasan, V., Steyaert, J., & Barlow, J. N. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.017 · Cited by 37 · see citing works
Positive-unlabeled learning for the prediction of conformational B-cell epitopes
Ren, J., Liu, Q., Ellis, J., & Li, J. (2015) · BMC Bioinformatics · doi:10.1186/1471-2105-16-s18-s12 · Cited by 34 · see citing works
Rudolph, M. J., Vance, D. J., Cassidy, M. S., Rong, Y., & Mantis, N. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.758102 · Cited by 24 · see citing works
Moonens, K., den Broeck, I. V., Okello, E., Pardon, E., Kerpel, M. D., Remaut, H. K., & Greve, H. D. (2015) · Veterinary Research · doi:10.1186/s13567-015-0151-x · Cited by 24 · see citing works
Günaydın, G., Yu, S., Gräslund, T., Hammarström, L. L. G., & Marcotte, H. (2016) · Scientific Reports · doi:10.1038/srep30171 · Cited by 22 · see citing works
Barros-Álvarez, X., Kerchner, K. M., Koh, C. Y., Turley, S., Pardon, E., Steyaert, J., Ranade, R. M., Gillespie, J. R., Zhang, Z., Verlinde, C. L. M. J., et al. (2017) · Biochimie · doi:10.1016/j.biochi.2017.04.006 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The therapeutic potential of nanobodies
Jovčevska, I., & Muyldermans, S. (2020) · BioDrugs · doi:10.1007/s40259-019-00392-z · Cited by 749 · see citing works
NANOBODIES®: A Review of Diagnostic and Therapeutic Applications
Jin, B.-K., Odongo, S., Radwanska, M., & Magez, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065994 · Cited by 387 · see citing works
A guide to: generation and design of nanobodies
Muyldermans, S. (2020) · FEBS Journal · doi:10.1111/febs.15515 · Cited by 352 · see citing works
Muyldermans, S. (2020) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021419-083831 · Cited by 335 · see citing works
Immunogenicity and humanization of single‐domain antibodies
Rossotti, M. A., Bélanger, K., Henry, K. A., & Tanha, J. (2021) · FEBS Journal · doi:10.1111/febs.15809 · Cited by 174 · see citing works
Theranostics in immuno-oncology using nanobody derivatives
Lecocq, Q., Vlaeminck, Y. D., Hanssens, H., D’Huyvetter, M., Raes, G., Goyvaerts, C., Keyaerts, M., Devoogdt, N., & Breckpot, K. (2019) · Theranostics · doi:10.7150/thno.34941 · Cited by 145 · see citing works
Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments
Sandomenico, A., Sivaccumar, J. P., & Ruvo, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176324 · Cited by 134 · see citing works
“The extended CDR3 loop of nanobodies has the capacity to form a finger-like structure with greater structural flexibility which, in turn, is likely fixed in one single conformation upon antigen-binding [14,15].”
BackgroundRapid generation of potent antibodies by autonomous hypermutation in yeast
Wellner, A., McMahon, C. T., Gilman, M. S. A., Clements, J. R., Clark, S. A., Nguyen, K. M., Ho, M. H., Hu, V. J., Shin, J.-E., Feldman, J. E., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00832-4 · Cited by 128 · see citing works
Mahdavi, S. Z. B., Oroojalian, F., Eyvazi, S., Hejazi, M., Baradaran, B., Pouladi, N., Tohidkia, M. R., Mokhtarzadeh, A., & Muyldermans, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.113 · Cited by 109 · see citing works
Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
Arbabi‐Ghahroudi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095009 · Cited by 95 · see citing works
Exploring cellular biochemistry with nanobodies
Cheloha, R. W., Harmand, T. J., Wijne, C., Schwartz, T., & Ploegh, H. L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.012960 · Cited by 92 · see citing works
Su, B., Zhang, Z., Sun, Z., Tang, Z., Xie, X., Chen, Q., Cao, H., Yu, X., Xu, Y., Liu, X., et al. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126838 · Cited by 88 · see citing works
Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells
Groof, T. W. M. D., Mashayekhi, V., Fan, T. S., Bergkamp, N. D., Toraño, J. S., van Senten, J. R., Heukers, R., Smit, M. J., & Oliveira, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00360 · Cited by 82 · see citing works
Nanobodies: Robust miniprotein binders in biomedicine
Kim, J. Y. J., Sang, Z., Xiang, Y., Shen, Z., & Shi, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114726 · Cited by 78 · see citing works
Application of Single-Domain Antibodies (“Nanobodies”) to Laboratory Diagnosis
Pillay, T. S., & Muyldermans, S. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.6.549 · Cited by 74 · see citing works
Single-domain near-infrared protein provides a scaffold for antigen-dependent fluorescent nanobodies
Oliinyk, O. S., Baloban, M., Clark, C. L., Carey, E. M., Pletnev, S. V., Nimmerjahn, A., & Verkhusha, V. V. (2022) · Nature Methods · doi:10.1038/s41592-022-01467-6 · Cited by 72 · see citing works
Research progress and applications of nanobody in human infectious diseases
Mei, Y., Chen, Y., Sivaccumar, J. P., An, Z., Xia, N., & Luo, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.963978 · Cited by 70 · see citing works
Nanobody Conjugates for Targeted Cancer Therapy and Imaging
Kang, W., Ding, C., Zheng, D., Ma, X., Yi, L., Tong, X., Wu, C., Xue, C., Yu, Y., & Zhou, Q. (2021) · Technology in Cancer Research & Treatment · doi:10.1177/15330338211010117 · Cited by 62 · see citing works
Kang, S., Davidsen, K., Gomez-Castillo, L., Jiang, H., Fu, X., Li, Z., Liang, Y. T., Jahn, M., Moussa, M., DiMaio, F., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03522 · Cited by 61 · see citing works
Computational design and modeling of nanobodies toward SARS‐CoV‐2 receptor binding domain
Yang, J., Zhang, Z., Yang, F., Zhang, H., Wu, H., Zhu, F., & Xue, W. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13847 · Cited by 55 · see citing works
Homology Modeling-Based in Silico Affinity Maturation Improves the Affinity of a Nanobody
Cheng, X. M., Wang, J., Kang, G., Hu, M., Yuan, B., Zhang, Y., & Huang, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174187 · Cited by 55 · see citing works
Nanobodies: The Future of Antibody-Based Immune Therapeutics
Bathula, N. V., Bommadevara, H., & Hayes, J. M. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.3941 · Cited by 55 · see citing works
Abdolvahab, M. H., Karimi, P., Mohajeri, N., Abedini, M., & Zare, H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03259-8 · Cited by 51 · see citing works
Akiba, H., Tamura, H., Kiyoshi, M., Yanaka, S., Sugase, K., Caaveiro, J. M. M., & Tsumoto, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-50722-y · Cited by 48 · see citing works
Prospects for the computational humanization of antibodies and nanobodies
Gordon, G. L., Raybould, M. I. J., Wong, A., & Deane, C. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1399438 · Cited by 47 · see citing works
Lu, Q., Li, X., Zhao, J., Zhu, J.-H., Luo, Y., Duan, H. Q., Ji, P., Wang, K., Liu, B., Wang, X., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0568-x · Cited by 47 · see citing works
Nanobodies: From High-Throughput Identification to Therapeutic Development
Fridy, P. C., Rout, M. P., & Ketaren, N. E. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100865 · Cited by 41 · see citing works
Lucas, A. T., Moody, A., Schorzman, A. N., & Zamboni, W. C. (2021) · Antibodies · doi:10.3390/antib10030030 · Cited by 40 · see citing works
Liu, J., Wu, L., Xie, A., Liu, W. L., Zhao, H., Wan, Y., & Mao, W. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03169-5 · Cited by 41 · see citing works
A comparison of the binding sites of antibodies and single-domain antibodies
Gordon, G. L., Capel, H., Guloglu, B., Richardson, E., Stafford, R., & Deane, C. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1231623 · Cited by 38 · see citing works
Current status and future expectations of nanobodies in oncology trials
Pauw, T. D., Mey, L. D., Debacker, J. M., Raes, G., Ginderachter, J. A. V., Groof, T. W. M. D., & Devoogdt, N. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2249814 · Cited by 38 · see citing works
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
Salamouni, N. S. E., Cater, J. H., Spenkelink, L. M., & Yu, H. B. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13850 · Cited by 36 · see citing works
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
Favorskaya, I. A., Shcheblyakov, D. V., Esmagambetov, I. B., Dolzhikova, I. V., Alekseeva, I. A., Korobkova, A. I., Voronina, D. V., Ryabova, E. I., Derkaev, A. A., Витальевна, К. А., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.822159 · Cited by 36 · see citing works
Kinoshita, S., Nakakido, M., Mori, C., Kuroda, D., Caaveiro, J. M. M., & Tsumoto, K. (2022) · Protein Science · doi:10.1002/pro.4450 · Cited by 35 · see citing works
Kaur, H., Hartmann, J.-B., Jakob, R. P., Zahn, M., Zimmermann, I., Maier, T., Seeger, M. A., & Hiller, S. (2019) · Journal of Biomolecular NMR · doi:10.1007/s10858-019-00250-8 · Cited by 34 · see citing works
Advancements in Nanobody Epitope Prediction: A Comparative Study of AlphaFold2Multimer vs AlphaFold3
Eshak, F., & Goupil-Lamy, A. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01877 · Cited by 34 · see citing works
Single-domain antibodies as therapeutics for solid tumor treatment
Wang, M., Ying, T., & Wu, Y. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.016 · Cited by 33 · see citing works
Ikeuchi, E., Kuroda, D., Nakakido, M., Murakami, A., & Tsumoto, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-98977-8 · Cited by 32 · see citing works
Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
Yü, S., Gui, X., Zhao, S., Tang, Y., Tang, H., Wang, K., Liu, H., Lan, K., Bi, X., & Duan, S. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4817 · Cited by 29 · see citing works
Downsizing antibodies: Towards complementarity-determining region (CDR)-based peptide mimetics
holsbeeck, K. V., Martins, J. C., & Ballet, S. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105563 · Cited by 29 · see citing works
Small but mighty: the versatility of nanobodies in modern medicine
Blueggel, M., Gül, D., Stauber, R. H., & Knauer, S. K. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00283d · Cited by 28 · see citing works
Nanobodies – Little helpers unravelling intracellular signaling
Wagner, T. R., & Rothbauer, U. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.005 · Cited by 27 · see citing works
Structural Classification of CDR-H3 in Single-Domain VHH Antibodies
Kuroda, D., & Tsumoto, K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2609-2_2 · Cited by 27 · see citing works
Liu, C., Lin, H., Cao, L., Wang, K., & Sui, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059771 · Cited by 24 · see citing works
Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
Cross, F. R., Fridy, P. C., Ketaren, N. E., Mast, F. D., Li, S., Olivier, J. P., Pecani, K., Chait, B. T., Aitchison, J. D., & Rout, M. P. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102954 · Cited by 22 · see citing works
Evers, A., Guarnera, E., Pekar, L., & Zielonka, S. (2025) · mAbs · doi:10.1080/19420862.2025.2583210 · Cited by 21 · see citing works
Kang-Pettinger, T., Walker, K., Brown, R., Cowan, R. H., Wright, H., Baravalle, R., Waters, L. C., Muskett, F. W., Bowler, M. W., Sawmynaden, K., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102769 · Cited by 21 · see citing works
Identification of nanobodies against hepatocellular carcinoma marker glypican-3
Wang, W., Xu, C., Wang, H., & Jiang, C. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.01.010 · Cited by 20 · see citing works
Structure and Dynamics Guiding Design of Antibody Therapeutics and Vaccines
Fernández‐Quintero, M. L., Pomarici, N. D., Fischer, A.-L. M., Hoerschinger, V. J., Kroell, K. B., Riccabona, J. R., Kamenik, A. S., Loeffler, J. R., Ferguson, J. A., Perrett, H. R., et al. (2023) · Antibodies · doi:10.3390/antib12040067 · Cited by 19 · see citing works
Unique mechanisms to increase structural stability and enhance antigen binding in nanobodies
Ketaren, N. E., Fridy, P. C., Malashkevich, V. N., Sanyal, T., Brillantes, M., Thompson, M. K., Oren, D. A., Bonanno, J. B., Šali, A., Almo, S. C., et al. (2025) · Structure · doi:10.1016/j.str.2025.01.019 · Cited by 19 · see citing works
Voss, M., Toelzer, C., Bhandari, D. D., Parker, J. E., & Niefind, K. (2019) · Journal of Structural Biology · doi:10.1016/j.jsb.2019.09.007 · Cited by 19 · see citing works
Majerle, A., Hadži, S., Aupič, J., Satler, T., Lapenta, F., Strmšek, Ž., Lah, J., Loris, R., & Jerala, R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021899118 · Cited by 17 · see citing works
Self-citationNbX: Machine Learning-Guided Re-Ranking of Nanobody–Antigen Binding Poses
Tam, C., Kumar, A., & Zhang, K. Y. J. (2021) · Pharmaceuticals · doi:10.3390/ph14100968 · Cited by 17 · see citing works
A non-redundant data set of nanobody-antigen crystal structures
Zavrtanik, U., & Hadži, S. (2019) · Data in Brief · doi:10.1016/j.dib.2019.103754 · Cited by 17 · see citing works
Self-citationYu, H., Mao, G., Pei, Z., Cen, J., Meng, W., Wang, Y., Zhang, S., Li, S., Xu, Q., Sun, M., et al. (2023) · Molecules · doi:10.3390/molecules28196838 · Cited by 16 · see citing works
Nanobody Paratope Ensembles in Solution Characterized by MD Simulations and NMR
Fernández‐Quintero, M. L., DeRose, E. F., Gabel, S. A., Mueller, G. A., & Liedl, K. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105419 · Cited by 16 · see citing works
Stahl, P., Kollenda, S., Sager, J., Schmidt, L., Schroer, M. A., Stauber, R. H., Epple, M., & Knauer, S. K. (2023) · Small · doi:10.1002/smll.202300871 · Cited by 15 · see citing works
Single‐Domain Antibody‐Based TCR‐Like CAR‐T: A Potential Cancer Therapy
Zhu, L., Yang, X., Zhong, D., Xie, S., Shi, W., Li, Y., Hou, X., HuaYao, Zhou, H., Zhao, M., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/2454907 · Cited by 14 · see citing works
Nanobody-Based Drug Delivery: Emerging Strategies for Targeted Cancer Therapy
Ghosh, N., Sepay, N., Paul, M., & Im, J. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s584604 · Cited by 14 · see citing works
PLAbDab-nano: a database of camelid and shark nanobodies from patents and literature
Gordon, G. L., Greenshields‐Watson, A., Agarwal, P., Wong, A., Boyles, F., Hummer, A. M., Hernandez, A. G. L., & Deane, C. M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae881 · Cited by 13 · see citing works
Kumar, S., Mahendran, I., Athreya, A., Ranjan, R. D., & Penmatsa, A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010902 · Cited by 13 · see citing works
Computer-guided library generation applied to the optimization of single-domain antibodies
Akiba, H., Tamura, H., Caaveiro, J. M. M., & Tsumoto, K. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzaa006 · Cited by 13 · see citing works
A whole-cell platform for discovering synthetic cell adhesion molecules in bacteria
Chen, P.-Y., Chen, Y.-C., Chen, P.-P., Lin, K.-T., Sargsyan, K., Hsu, C., Wang, W.-L., Hsia, K., & Ting, S. (2024) · Nature Communications · doi:10.1038/s41467-024-51017-1 · Cited by 12 · see citing works
Development of novel humanized VHH synthetic libraries based on physicochemical analyses
Nakakido, M., Kinoshita, S., & Tsumoto, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-70513-4 · Cited by 12 · see citing works
Interaction standards for biophysics: anti-lysozyme nanobodies
Birchenough, H. L., Nivia, H. D. R., & Jowitt, T. A. (2021) · European Biophysics Journal · doi:10.1007/s00249-021-01524-6 · Cited by 12 · see citing works
Development of nanobodies against Staphylococcus enterotoxin B through yeast surface display
Ming, K., Hu, Y., Zhu, M. J., Xing, B., Mei, M., & Wei, Z. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126822 · Cited by 12 · see citing works
Yep, A. T., Takeuchi, Y., Engelhardt, O. G., & Hufton, S. E. (2021) · Biomolecules · doi:10.3390/biom11030407 · Cited by 12 · see citing works
Smorodina, E., Ali, M., Kropivšek, K., Salicari, L., Miklavc, S., Kappassov, A., Fu, C., Sormanni, P., de Marco, A., & Greiff, V. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.02.709004 · Cited by 12 · see citing works
Breine, A., holsbeeck, K. V., Martin, C., González, S., Mannes, M., Pardon, E., Steyaert, J., Remaut, H. K., Ballet, S., & der Henst, C. V. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00116 · Cited by 11 · see citing works
Liu, X., Wang, C., Bai, Y., Wang, W., Han, Y., Cai, S., An, J., & Qu, G. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106615 · Cited by 11 · see citing works
Gordon, G. L., Gervásio, J. H. D. B., Souders, C., & Deane, C. M. (2026) · Communications Biology · doi:10.1038/s42003-026-09594-y · Cited by 11 · see citing works
Targeting Ras-binding domain of ELMO1 by computational nanobody design
Tam, C., Kukimoto‐Niino, M., Miyata-Yabuki, Y., Tsuda, K., Mishima-Tsumagari, C., Ihara, K., Inoue, M., Yonemochi, M., Hanada, K., Matsumoto, T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04657-w · Cited by 11 · see citing works
Peptide barcoding for one-pot evaluation of sequence–function relationships of nanobodies
Matsuzaki, Y., Aoki, W., Miyazaki, T., Aburaya, S., Ohtani, Y., Kajiwara, K., Koike, N., Minakuchi, H., Miura, N., Kadonosono, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01019-6 · Cited by 10 · see citing works
A single-domain antibody library based on a stability-engineered human VH3 scaffold
Lee, N. J., Jung, M., Yang, H. Y., & Shim, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-68680-5 · Cited by 9 · see citing works
Ranjbari, S., Almahmeed, W. A., Kesharwani, P., & Sahebkar, A. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111867 · Cited by 9 · see citing works
Ünsal, S., Holland, B., Sardag, I., & Timuçin, E. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag137 · Cited by 9 · see citing works
Ferraz, M. V. F., Neto, J. C. S., Lins, R. D., & Teixeira, E. S. (2023) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp05644e · Cited by 9 · see citing works
Mortelecque, J., Zejneli, O., Bégard, S., Simões, M. C., Hajjar, L. E., Nguyen, M., Cantrelle, F., Hanoulle, X., Rain, J., Colin, M., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107163 · Cited by 9 · see citing works
Sherwood, L. J., Taylor, A. B., Hart, P. J., & Hayhurst, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.10.005 · Cited by 9 · see citing works
Production of Single-Domain Antibodies in Pichia pastoris
Matsuzaki, Y., Kajiwara, K., Aoki, W., & Ueda, M. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2075-5_9 · Cited by 9 · see citing works
Liu, C., Han, X., Li, G., Zhang, T., Chen, Y., Cao, L., Lin, H., & Sui, J. (2022) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c00691 · Cited by 9 · see citing works
Structural insights into the role and targeting of EGFRvIII
Bagchi, A., Stayrook, S. E., Xenaki, K. T., Starbird, C. A., Doulkeridou, S., el Khoulati, R., Roovers, R. C., Schmitz, K. R., Henegouwen, P. M. P. V. B. E., & Ferguson, K. M. (2024) · Structure · doi:10.1016/j.str.2024.05.018 · Cited by 8 · see citing works
Nanobodies: A Promising Toolkit for Diagnostic Applications
Wu, W., Ali, A., Sun, L., Hu, J., Hameed, L., Shafi, S., Raza, A., Dinislam, K., Xing, W., Rong, L., et al. (2026) · SmartMat · doi:10.1002/smm2.70088 · Cited by 8 · see citing works
Yamamoto, K., Nagatoishi, S., Matsunaga, R., Nakakido, M., Kuroda, D., & Tsumoto, K. (2023) · Protein Science · doi:10.1002/pro.4827 · Cited by 8 · see citing works
Meltzer, M., Eliash, N., Azoulay, Z., Hadad, U., & Papo, N. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04336-9 · Cited by 8 · see citing works
Designing stable humanized antibodies
Hummer, A. M., & Deane, C. M. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01168-1 · Cited by 8 · see citing works
Nanobody CAR-T cells in cancer: From molecular design to clinical translation
Eisa, A. R., Razavi, F. T., Hoseinzadeh, A., Haghmorad, D., & Baharlou, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118819 · Cited by 7 · see citing works
Applications of High-Throughput DNA Sequencing to Single-Domain Antibody Discovery and Engineering
Lowden, M. J., Lei, E. K., Hussack, G., & Henry, K. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3381-6_26 · Cited by 7 · see citing works
Single-chain dimers from de novo immunoglobulins as robust scaffolds for multiple binding loops
Roel‐Touris, J., Nadal, M., & Marcos, E. (2023) · Nature Communications · doi:10.1038/s41467-023-41717-5 · Cited by 7 · see citing works
Ribeiro, R., Moreira, J. N., & Gonçalves, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-61230-z · Cited by 7 · see citing works
Enthalpy‐ versus Entropy‐Driven Molecular Recognition in the Era of Biologics
Varese, M., Guardiola, S., García, J., & Giralt, E. (2019) · ChemBioChem · doi:10.1002/cbic.201900270 · Cited by 7 · see citing works
Development of a synthetic library of humanized nanobodies for targeted IL-6 inhibition
Wang, L., Dong, J., Wu, C., Yan, C., Bi, C., Xu, C., Wu, Y., Zheng, W., & Xing-yuan, M. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1440150 · Cited by 6 · see citing works
Nanobody-as versatile tool emerging in autoimmune diseases
Wang, L., Luo, R., Zhang, W., Jiang, H., Yu, Y., Zhou, W., Zhang, F., Ma, J., & Mei, L. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.10.003 · Cited by 6 · see citing works
Yamamoto, K., Nagatoishi, S., Matsunaga, R., Nakakido, M., Kuroda, D., & Tsumoto, K. (2025) · Protein Science · doi:10.1002/pro.70095 · Cited by 6 · see citing works
Gaudreault, F., Corbeil, C. R., Purisima, E. O., & Sulea, T. I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.884132 · Cited by 6 · see citing works
Molecular engineering of nanobodies as tools in allergology: diagnostics and beyond
Aagaard, J. B., Ballegaard, A. R., Ommen, P., & Spillner, E. (2023) · Allergo Journal International · doi:10.1007/s40629-023-00261-w · Cited by 6 · see citing works
Gettemans, J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2075-5_19 · Cited by 6 · see citing works
Henry, K. A., Hussack, G., Kumaran, J., Gilbert, M., MacKenzie, C. R., Sulea, T. I., & Arbabi‐Ghahroudi, M. (2019) · Journal of Molecular Recognition · doi:10.1002/jmr.2805 · Cited by 6 · see citing works
Potential and limitations of epitope mapping and molecular targeting in Hymenoptera venom allergy
Fernandes, L. G. R., Spillner, E., & Jakob, T. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1327391 · Cited by 5 · see citing works
Nanobody-based imaging: Advancing precision in molecular diagnostics
Eftekhari, Z., & Kazemi‐Lomedasht, F. (2025) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2025.130884 · Cited by 5 · see citing works
- Authors
- Zavrtanik, U., Lukan, J., Loris, R., Lah, J., & Hadži, S.
- Affiliations
- University of Ljubljana (SI)
- Statistical Office of the Republic of Slovenia (SI)
- Vrije Universiteit Brussel (BE)
- Corresponding author
- Hadži, San
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 430
- Issue
- 21
- Pages
- 4369-4386
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2891129333
- Cited by
- 169
- References
- 87
- Citations by year
- 2026: 21 · 2025: 25 · 2024: 26 · 2023: 30 · 2022: 22 · 2021: 19 · 2020: 12 · 2019: 14
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Slovenian Research Agency (P1-0201)
- Onderzoeksraad of the Vrije Universiteit Brussel (SPR13)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
- Keywords
- nanobodies, heavy-chain antibodies, camelid antibodies, epitope recognition, antibody binding sites, aromatic residues, hydrophobic interactions, CDR loops, binding affinity, solvation entropy, protein-protein interaction, crystal structure
- MeSH terms
- Camelidae, Animals, Epitopes, Binding Sites, Binding Sites, Antibody, Camelids, New World, Immunoglobulin Heavy Chains, Models, Molecular, Protein Binding, Crystallography, X-Ray, Single-Domain Antibodies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review